|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM28527015X |
003 |
DE-627 |
005 |
20231225045051.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2018 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1111/jfd.12828
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0950.xml
|
035 |
|
|
|a (DE-627)NLM28527015X
|
035 |
|
|
|a (NLM)29882295
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Nguyen, Hai Trong
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Enhanced immune responses and effectiveness of refined outer membrane protein vaccines against Vibrio harveyi in orange-spotted grouper (Epinephelus coioides)
|
264 |
|
1 |
|c 2018
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 30.01.2019
|
500 |
|
|
|a Date Revised 30.09.2020
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2018 John Wiley & Sons Ltd.
|
520 |
|
|
|a Vibriosis is a severe infection occurring in many commercially important marine fish species. In this study, vaccines containing Vibrio harveyi recombinant outer membrane protein K (rOmpK), outer membrane protein U (rOmpU) and rOmpK-OmpU fusion protein in addition to the metabolizable MontanideTM ISA 763 A VG adjuvant were developed and evaluated in the orange-spotted grouper. The results indicate that recombinant V. harveyi protein-based vaccines resulted in a remarkably higher expression of IL-1β and IL-8 at 24 hr, and greater antibody production, as early as 2 weeks postimmunization. Notably, enhanced immune responses and significant protective efficacy against V. harveyi infections were observed in the fusion protein vaccine-injected fishes with relative per cent survival value of 81.8%. Additionally, the rOmpK-OmpU antisera presented a high bactericidal effect on not only V. harveyi, but also Vibrio parahaermolyticus and Vibrio alginolyticus. Our results demonstrated that the fusion protein rOmpK-OmpU was an effective vaccine candidate that exhibited potentially great versatility for controlling vibrio infections
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Vibrio harveyi
|
650 |
|
4 |
|a ISA 763 A VG
|
650 |
|
4 |
|a fusion protein
|
650 |
|
4 |
|a vaccine
|
650 |
|
4 |
|a vibriosis
|
650 |
|
7 |
|a Adjuvants, Immunologic
|2 NLM
|
650 |
|
7 |
|a Antibodies, Bacterial
|2 NLM
|
650 |
|
7 |
|a Bacterial Outer Membrane Proteins
|2 NLM
|
650 |
|
7 |
|a Bacterial Vaccines
|2 NLM
|
650 |
|
7 |
|a Fish Proteins
|2 NLM
|
650 |
|
7 |
|a Interleukin-1beta
|2 NLM
|
650 |
|
7 |
|a Interleukin-8
|2 NLM
|
650 |
|
7 |
|a Recombinant Proteins
|2 NLM
|
700 |
1 |
|
|a Nguyen, Thuy Thi Thu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Yan-Chun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Vu-Khac, Hung
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Pei-Chi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Shih-Chu
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Journal of fish diseases
|d 1998
|g 41(2018), 9 vom: 08. Sept., Seite 1349-1358
|w (DE-627)NLM098166034
|x 1365-2761
|7 nnns
|
773 |
1 |
8 |
|g volume:41
|g year:2018
|g number:9
|g day:08
|g month:09
|g pages:1349-1358
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1111/jfd.12828
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 41
|j 2018
|e 9
|b 08
|c 09
|h 1349-1358
|